Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Monday, December 24 through Wednesday, December 26 inclusive. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 04.02.16 in Vol 5, No 1 (2016): Jan-Mar

This paper is in the following e-collection/theme issue:

Works citing "Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.4473):

(note that this is only a small subset of citations)

  1. Alsop J, Medin J, Cornelissen C, Vormfelde SV, Ziemssen T, Ramagopalan SV. Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL. PLOS ONE 2017;12(5):e0173353
    CrossRef
  2. Ziemssen T, Hillert J, Butzkueven H. The importance of collecting structured clinical information on multiple sclerosis. BMC Medicine 2016;14(1)
    CrossRef